Clinical trial
A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.
NCT00232856 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00232856 |
|---|---|
| Title | A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions. |
| Official title | A Multi-Center, Non-Randomised Study of the CYPHER™ Sirolimus-Eluting Stent in the Treatment of Patient With an in-Stent Restenotic Native Coronary Artery Lesion |
| Acronym | TROPICAL |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | drug-eluting stent |
| Enrollment | 162 |
| Start date | Dec 1, 2002 |
| Primary completion | Dec 1, 2003 |
| Completion | Aug 1, 2006 |
| First posted | Oct 5, 2005 |
| Last update posted | Apr 30, 2008 |
| Countries | Belgium, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: